|
rs121913530
|
|
A |
0.880 |
CausalMutation |
CLINVAR |
|
|
|
|
rs121913530
|
|
|
0.880 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs1051730
|
|
T |
0.800 |
GeneticVariation |
GWASCAT |
Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk.
|
30104567 |
2018 |
|
rs121909071
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.
|
24846033 |
2014 |
|
rs121909071
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.
|
25311215 |
2014 |
|
rs121909071
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.
|
24627688 |
2014 |
|
rs121913351
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.
|
24627688 |
2014 |
|
rs121913351
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.
|
24846033 |
2014 |
|
rs121913351
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.
|
25311215 |
2014 |
|
rs121913529
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
rs121913529
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation.
|
25044103 |
2014 |
|
rs121909071
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group.
|
23667368 |
2013 |
|
rs121909071
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
|
23562183 |
2013 |
|
rs121913351
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group.
|
23667368 |
2013 |
|
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
|
23833300 |
2013 |
|
rs121913351
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
|
23562183 |
2013 |
|
rs13181
|
|
C |
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer.
|
23108145 |
2013 |
|
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.
|
22649091 |
2012 |
|
rs121913529
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.
|
23014527 |
2012 |
|
rs2736100
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.
|
23143601 |
2012 |
|
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.
|
21483012 |
2011 |
|
rs2736100
|
|
C |
0.800 |
GeneticVariation |
GWASCAT |
The combined analyses identified six well-replicated SNPs with independent effects and significant lung cancer associations (P < 5.0 × 10(-8)) located in TP63 (rs4488809 at 3q28, P = 7.2 × 10(-26)), TERT-CLPTM1L (rs465498 and rs2736100 at 5p15.33, P = 1.2 × 10(-20) and P = 1.0 × 10(-27), respectively), MIPEP-TNFRSF19 (rs753955 at 13q12.12, P = 1.5 × 10(-12)) and MTMR3-HORMAD2-LIF (rs17728461 and rs36600 at 22q12.2, P = 1.1 × 10(-11) and P = 6.2 × 10(-13), respectively).
|
21725308 |
2011 |
|
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
|
rs8034191
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
A meta-analysis provided increased support that variation at 15q25.1 (rs8034191; P = 3.24 x 10(-26)), 5p15.33 (rs4975616; P = 2.99 x 10(-9)), and 6p21.33 (rs3117582; P = 4.46 x 10(-10)) influences lung cancer risk.
|
19654303 |
2009 |
|
rs1051730
|
|
A |
0.800 |
GeneticVariation |
GWASCAT |
Lung cancer susceptibility locus at 5p15.33.
|
18978790 |
2008 |